Webinars

Tuesday, December 1, 2026, 2:00 pm ET

Darryl Drevna, MA, Senior Director, Regulatory Affairs, AMGA
Alicia Sawyer, Government Relations Assistant, AMGA

This webinar will provide AMGA members with an understanding of the CY 2027 Medicare Physician Fee Schedule (PFS) Final Rule, including the following key topics:

• Finalized conversion factors of $32.95 for qualifying APM participants (-1.83%) and $32.63 for all other clinicians (-2.31%), deeper cuts than proposed, driven largely by the expiration of the one-year 2.5% CY 2026 increase

• Reduced payment when an office/outpatient E/M visit is furnished on the same day as a 0-day global procedure, with the lower-cost service paid at 80% (modified from the proposed 50% and narrowed from 10- and 90-day globals)

• Replacement of the G2211 complexity add-on code with modifiers that increase E/M payment by 16%, or by 32% for practitioners in Shared Savings Program and LEAD Model ACOs

• Practice expense methodology changes, including a two-year phase-out of the indirect practice cost index and a new PE stabilizer

• Remote physiologic and therapeutic monitoring changes, with the employed clinical staff requirement delayed to January 1, 2029

• Medicare Shared Savings Program changes, including the option for ACOs to reduce or eliminate Part B cost sharing beginning April 1, 2027, higher shared savings rates for eligible ACOs, and new incentives for first-time participants

• Quality Payment Program changes, including the sunset of traditional MIPS beginning with the CY 2031 performance period (two years later than proposed), three new MVPs, and a required specialty-specific Core Measure beginning in CY 2027

Thursday, December 10, 2026, 2:00 pm ET

Darryl Drevna, MA, Senior Director, Government Relations, AMGA
Alicia Sawyer, Government Relations Assistant, AMGA

This webinar will provide AMGA members with an understanding of the CY 2027 Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Final Rule, including the following key topics:

• Finalized 2.3% increase to OPPS and ASC payment rates (down from 2.4% proposed), reflecting a 3.2% hospital market basket update reduced by a 0.9 percentage point productivity adjustment

• Continued 2 percentage point payment reduction for hospitals that do not meet Hospital Outpatient Quality Reporting Program requirements

• Finalized payment for 340B-acquired drugs at ASP minus 28% (rather than the proposed ASP minus 33.4%), offset by a budget-neutral 7.5% increase for non-drug services; non-340B drugs remain at ASP plus 6%

• Accelerated 340B remedy recoupment: the conversion factor offset increases from 0.5% to 2% (rather than the proposed 3%), with the $7.8 billion expected to be fully recovered by CY 2031

• Finalized expansion of site-neutral payments to imaging services without contrast furnished in excepted off-campus provider-based departments, paid at the PFS-equivalent rate, with an exemption for rural sole community hospitals

• Continued phase-out of the Inpatient Only list (637 services removed) and addition of 618 procedures to the ASC Covered Procedures List

• Other finalized policies, including prior authorization for eight additional botulinum toxin injection codes, payment for Software as a Medical Service (SaMS), quality reporting program updates, and changes to the Overall Hospital Quality Star Rating methodology

• Key implementation considerations ahead of the January 1, 2027 effective date